CYSTEINE HYDROCHLORIDE | N210660 | EXELA PHARMA SCIENCES LLC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| PGR2020-00064 | 10478453 | PGR | Eton Pharmaceuticals, Inc. | Institution Denied | 2020-05-19 | — |
| PGR2020-00068 | 10583155 | PGR | Eton Pharmaceuticals Inc. | Institution Denied | 2020-06-08 | — |
| PGR2020-00086 | 10653719 | PGR | Eton Pharmaceuticals, Inc. | Institution Denied | 2020-09-21 | — |
| PGR2024-00016 | 11642370 | PGR | Nexus Pharmaceuticals LLC | Institution Denied | 2024-02-08 | 2024-08-08 |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Exela Pharma Sciences, LLC v. Hikma Pharmaceuticals USA Inc. 2 patentsANDA 213073L-cysteine hydrochloride | D. Del. | 2023-02-06 | Terminated 2023-06-30 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 10478453 | Jan 15, 2039 | — | — | Yes | — | |
| 10583155 | Jan 15, 2039 | — | — | Yes | — | |
| 10653719 | Jan 15, 2039 | — | — | Yes | — | — |
| 10905713 | Jan 15, 2039 | — | — | Yes | — | — |
| 10905714 | Jan 15, 2039 | — | — | Yes | — | — |
| 10912795 | Jan 15, 2039 | — | — | Yes | — | — |
| 10918662 | Jan 15, 2039 | — | — | Yes | — | — |
| 10933089 | Jan 15, 2039 | — | — | Yes | — | — |
| 11510941 | Jan 15, 2039 | — | — | Yes | — | — |
| 11510942 | Jan 15, 2039 | — | — | Yes | — | |
| 11642370 | Jan 15, 2039 | — | — | Yes | — | — |
| 11648262 | Jan 15, 2039 | — | — | Yes | — | — |
| 11679125 | Jan 15, 2039 | — | — | Yes | — | — |
| 11684636 | Jan 15, 2039 | — | — | Yes | — | — |
| 11826383 | Jan 15, 2039 | — | — | Yes | — | — |
| 11969439 | Jan 15, 2039 | — | — | — | — |